Marfan Syndrome (MFS) Medication Study
-
- STATUS
- Recruiting
Summary
Marfan Syndrome (MFS) Medication Study
Description
What is the purpose of this study?
This study will compare the effect of beta blocker therapy (Atenolol) to that of angiotensin II receptor blocker therapy (Losartan) on the rates of aortic growth and other cardiovascular outcomes.
What is involved?
This study lasts for three years and includes six visits. The following is a list of procedures that will take place during the study:
What are the benefits?
You or your child may or may not receive direct benefit from participating in this study comparing Atenolol or Losartan. The biggest benefit is that your child may be helping others with Marfan Syndrome. Clinical studies are essential in finding new and improved treatments.
Will I get all the facts about the study?
Parents and adult subjects will be given a consent form that thoroughly explains all of the details of the study. It includes all of the procedures, the risks, the benefits, the compensation, who to contact with questions or concerns, and more. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered. Study procedures will not begin until the parent/guardian or you, the participating study subject, have signed this form and, if of age, the child has given at minimum his/her verbal agreement.
What are the risks?
Although people usually tolerate both Losartan and Atenolol well, there is the potential of side effects whenever you take medication. Both Atenolol and Losartan are approved by the FDA and are taken by both children and adults. A detailed list of side effects will be provided to those patients interested in knowing more about the study.
What is the pay?
Participants will be reimbursed for travel and lodging. All study related tests and medications will be paid for by the study. All adult participants and parents of minor participants will receive $25 after the first three visits and $100 for each of the subsequent three annual visits. Additionally, minor participants will receive $20 gift cards after each visit.
Who will be included in this study?
Children, adolescents, and young adults, age 6 months to 25 years, with MFS who have aortic root dilation may be eligible to participate.
Who will be included in this study?
Children, adolescents, and young adults, age 6 months to 25 years, with MFS who have aortic root dilation may be eligible to participate.
Details
| Condition | Cardiovascular Abnormalities |
|---|---|
| Clinical Study Identifier | TX134366 |
| Last Modified on | 25 March 2021 |
Eligibility
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer